Find out how Abveris is transforming their antibody discovery processes with the Beacon® optofluidic system.
Download FileDr. Robert Carnahan, Ph.D., discusses how the Beacon system helped enable the rapid discovery functional antibodies against SARS-CoV-2.
Panelists from Genovac, will present case studies of how they have leveraged their core genetic immunization technology and the Beacon optofluidic system to rapidly discover antibodies against challenging targets, such as GPCRs, from a variety of different animal species.
Find out how Genovac is delivering 10-fold more lead candidates against difficult targets.